These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3440639

  • 21. Prophylactic antibiotics for elective colorectal surgery or operation for obstruction of the small bowel: a comparison of cefonicid and cefoxitin.
    Fabian TC, Mangiante EC, Boldreghini SJ.
    Rev Infect Dis; 1984; 6 Suppl 4():S896-900. PubMed ID: 6395280
    [Abstract] [Full Text] [Related]

  • 22. Penetration of cefonicid into human lung tissue and lymph nodes.
    Cazzola M, Polverino M, Guidetti E, Santangelo G, Paizis G, Monaco G, D'Amato G, Girbino G.
    Chemotherapy; 1990; 36(5):325-31. PubMed ID: 2209166
    [Abstract] [Full Text] [Related]

  • 23. Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.
    Chambers HF, Mills J, Drake TA, Sande MA.
    Rev Infect Dis; 1984; 6 Suppl 4():S870-4. PubMed ID: 6522927
    [Abstract] [Full Text] [Related]

  • 24. Use of long half-life parenteral cephalosporins in ambulatory practice.
    Sauerwein M, Deamer RL, Prichard JG.
    J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
    [Abstract] [Full Text] [Related]

  • 25. [Pulmonary and tonsillar distribution of ceftriaxone and cefonicid and the resultant bactericidal activity of the organ].
    Fraschini F, Scaglione F.
    Recenti Prog Med; 1990 Jan; 81(1):41-6. PubMed ID: 2236826
    [Abstract] [Full Text] [Related]

  • 26. Plasma and myocardial levels of cefonicid during open-heart surgery.
    Sterling RP, Connor DJ, Norman JC.
    J Natl Med Assoc; 1983 Nov; 75(11):1075-80. PubMed ID: 6655710
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
    Barriere SL, Gambertoglio JG, Alexander DP, Stagg RJ, Conte JE.
    Rev Infect Dis; 1984 Nov; 6 Suppl 4():S809-15. PubMed ID: 6522922
    [Abstract] [Full Text] [Related]

  • 28. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
    Wallace RJ, Niefield SL, Waters S, Waters B, Awe RJ, Wiss K, Martin RR, Greenberg SB.
    Antimicrob Agents Chemother; 1982 Feb; 21(2):231-5. PubMed ID: 7041813
    [Abstract] [Full Text] [Related]

  • 29. Cefonicid: a long-acting, second-generation cephalosporin. Antimicrobial activity, pharmacokinetics, clinical efficacy and adverse effects.
    Pontzer RE, Kaye D.
    Pharmacotherapy; 1984 Feb; 4(6):325-33. PubMed ID: 6393074
    [Abstract] [Full Text] [Related]

  • 30. Treatment of urinary tract infections in hospitalized patients: a double-blind comparison of cefonicid and cefamandole.
    Cox CE, Jacob LS.
    Rev Infect Dis; 1984 Feb; 6 Suppl 4():S839-43. PubMed ID: 6395273
    [Abstract] [Full Text] [Related]

  • 31. Cefonicid concentrations in human aqueous humor.
    Axelrod JL, Kochman RS.
    Arch Ophthalmol; 1984 Mar; 102(3):433-4. PubMed ID: 6608343
    [Abstract] [Full Text] [Related]

  • 32. Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery.
    Dudley MN, Nightingale CH, Drezner AD, Low HB, Quintiliani R.
    Antimicrob Agents Chemother; 1984 Sep; 26(3):347-50. PubMed ID: 6334490
    [Abstract] [Full Text] [Related]

  • 33. [Plasma and tissue concentrations of cefamandole during cardiac surgery].
    Clavey M, Weber M, Hubert T, Delanoë B, Poussot C, Hottier E, Villemot JP.
    Ann Fr Anesth Reanim; 1989 Sep; 8(4):316-20. PubMed ID: 2817542
    [Abstract] [Full Text] [Related]

  • 34. Stability of cefonicid sodium in infusion fluids.
    Wong WW, Maderich AB, Polli GP, Ravin LJ.
    Am J Hosp Pharm; 1985 Sep; 42(9):1980-3. PubMed ID: 4050816
    [Abstract] [Full Text] [Related]

  • 35. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Saltiel E, Brogden RN.
    Drugs; 1986 Sep; 32(3):222-59. PubMed ID: 3530703
    [Abstract] [Full Text] [Related]

  • 36. Prophylaxis against infection. Single-dose cefonicid compared with multiple-dose cefamandole.
    Garcia S, Lozano ML, Gatell JM, Soriano E, Ramon R, Sanmiguel JG.
    J Bone Joint Surg Am; 1991 Aug; 73(7):1044-8. PubMed ID: 1874767
    [Abstract] [Full Text] [Related]

  • 37. Antimicrobial prophylaxis for arthroplasty: a comparative study of cefonicid and cefazolin.
    Davis WA, Kane JG.
    Orthopedics; 1987 Oct; 10(10):1405-9. PubMed ID: 3317328
    [Abstract] [Full Text] [Related]

  • 38. Clinical efficacy of cefonicid in the treatment of staphylococcal infections.
    Lentnek AL, Evrard HM, Wikler MA, Sohn CA, Phillips SW.
    Clin Ther; 1985 Oct; 7(6):725-32. PubMed ID: 4075363
    [Abstract] [Full Text] [Related]

  • 39. Tissue penetration and half-life of cefonicid.
    Nightingale CH, Quintiliani R, Dudley MN, Gough P, Hickingbotham M, Jordan NS, Rose D, Toscani M.
    Rev Infect Dis; 1984 Oct; 6 Suppl 4():S821-8. PubMed ID: 6522924
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of cefonicid in patients with skin and skin structure infections.
    Heim-Duthoy KL, Peltier GL, Guay DR, Matzke GR.
    Antimicrob Agents Chemother; 1988 Apr; 32(4):485-7. PubMed ID: 3377460
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.